Results 151 to 160 of about 180,059 (262)

The E3 Ligase RNF115 Aggravates Pathological Cardiac Hypertrophy via Ubiquitin-Mediated Degradation of SPTBN1. [PDF]

Adv Sci (Weinh)
Zu Y, Chen S, Chen J, Ruan L, Li B, Chu W, Huang S, Yu D, Tian J, Zhao Y, Han Y, Tang X, Ji Y.   +12 more
europepmc   +1 more source

The Burden of Airway Disease in Mucopolysaccharidoses: Evidence Across Subtypes

The Laryngoscope, EarlyView.
ABSTRACT Objective To synthesize the prevalence and subtype‐specific patterns of airway manifestations in mucopolysaccharidoses (MPS) and summarize related morbidity and mortality. Data Sources PubMed, CINAHL, Ovid Embase, Ovid MEDLINE, and Ovid All EBM Reviews.
Julia Edward, Alix Pincivy, Mathieu Bergeron   +2 more
wiley   +1 more source

Histamine N-methyltransferase upregulation, cardiac hypertrophy, and heart failure. [PDF]

Eur Heart J
Zhang J, Jiang H, Liu L, Li X, Hong W, Xu L, Dong Z, Xu Z, Gao J, Sun X, Luo W, Liu J, Song Y, Wang P, Zhang J, Cui Y, Huang L, Zhou X, Zhang Y, Hu K, Yang J, Ge J, Sun A.   +22 more
europepmc   +1 more source

Exometabolomics Reveals Metabolic Modulation Induced by Chia Oil Supplementation in Adipose Tissue Explants From Obese Mice

Lipids, EarlyView.
The experimental design and the exometabolomic findings obtained by 1H‐NMR analysis of conditioned media from subcutaneous (SAT) and epididymal adipose tissue (EAT) explants of control and obese mice supplemented with chia oil (1.5% (w/w)). Following 8 weeks of control or high‐fat diet and 5 weeks of chia oil supplementation, SAT and EAT explants were ...
Gilson Costa dos Santos Jr, Agatha Assis‐Ferreira, Gabrielly Muniz‐Cassuce, Tatiana El Bacha, Christina Barja‐Fidalgo, Simone Vargas da Silva   +5 more
wiley   +1 more source

TFEB Antagonizes Cardiac Hypertrophy and Failure by Enhancing Lysosomal Capacity and Mitochondrial Function. [PDF]

Circ Res
Daou D, Das Gupta S, Anand A, May HI, Jiang N, Urquiza-Zurich S, Irion CI, Ferdous A, Garrido-Moreno V, Troncoso MF, Nguyen N, Maya-Ramos L, Dad Zada D, Olivares-Silva F, Chen G, Wu F, Diwan A, Kinter M, Maracaja-Coutinho V, Rothermel BA, Szweda LI, Lavandero S, Gillette TG, Hill JA.   +23 more
europepmc   +1 more source

Proteoforms in Disease: Biomedical Applications of Top‐Down Proteomics

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The proteome is a dynamic landscape of proteoforms arising from genetic mutations, alternative splicing, and post‐translational modifications (PTMs), which collectively drive biological function and disease phenotypes. Mass spectrometry (MS)‐based proteomics has emerged as an essential technique for elucidating this molecular complexity ...
Holden T. Rogers, Zachery R. Gregorich, Megan S. Gant, Zhan Gao, Julia Chamot‐Rooke, Ying Ge   +5 more
wiley   +1 more source

Sam68 Exacerbates Pathologic Cardiac Hypertrophy by Suppressing Cardiomyocyte Glucose Oxidation. [PDF]

Circulation
An J, Han C, Jiang Y, Shi J, Li H, Wang C, Huang J, Xu S, Ni J, Cao Y, Feng Y, Lyu Q, Dong N, Qin G.   +13 more
europepmc   +1 more source

Navigating the Complexity: A Comprehensive Review of GSK‐3 Inhibition in Regenerative Medicine

Medicinal Research Reviews, EarlyView.
ABSTRACT Glycogen synthase kinase‐3 (GSK‐3) is a central regulator of numerous cellular signaling pathways, with critical roles in metabolism, proliferation, differentiation, and tissue regeneration. This review explores the multifaceted effects of pharmacological GSK‐3 inhibition across multiple body districts, focusing on its highly context‐dependent
Davide Schiroli, Alessia Merra, Chiara Marraccini, Lucia Merolle, Graziella Pellegrini, Eleonora Maurizi   +5 more
wiley   +1 more source

The ADP-ribosyltransferases 3 (ART3) is a novel suppressor of pathological cardiac hypertrophy by ribosylating ITGA7. [PDF]

Acta Pharm Sin B
Meng Y, Hu S, Lin F, Zhu Y, Xiong Y, Sun Y, Lin Q, Lu M, Yi N, Xiao T, Wang H, Sheng J, Xu Y, Li C, Zhao C, Lu H, Sachinidis A, Li L, Peng L.   +18 more
europepmc   +1 more source

Cardiac Hypertrophy

, 2007
Ali J. Marian, James T. Willerson
openaire   +2 more sources